Physician profile
Mary E Patterson
NPI 1275821407
$1,732.37
in general payments reported to CMS, 2019-2025
19 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $403 · 2023: $450 · 2024: $319 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Education: $107 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.79 |
| Education | $106.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $554.31 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $346.02 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $143.88 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $121.43 | 2023-2025 | Gemtesa, Myfembree |
| Urovant Sciences INC | $87.81 | 2022 | |
| Pfizer INC. | $72.86 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $57.45 | 2022-2024 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $49.98 | 2021 | |
| Bausch Health US, LLC | $43.70 | 2022 | |
| Baxter Healthcare | $42.16 | 2025 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $38.84 | 2021-2024 | |
| Therapeuticsmd, INC. | $34.74 | 2022 | |
| Hologic Sales and Service, LLC | $24.07 | 2024 | Aptima |
| Laborie Medical Technologies Corp. | $23.43 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.37 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $20.19 | 2022 | |
| Dysis Medical, INC. | $18.77 | 2022 | |
| Agile Therapeutics, INC. | $16.44 | 2021 | |
| Daiichi Sankyo INC. | $15.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.